ARCOSA INC (ACA) Fundamental Analysis & Valuation

NYSE:ACA • US0396531008

Current stock price

114.43 USD
-0.01 (-0.01%)
At close:
114.43 USD
0 (0%)
After Hours:

This ACA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ACA Profitability Analysis

1.1 Basic Checks

  • ACA had positive earnings in the past year.
  • In the past year ACA had a positive cash flow from operations.
  • Each year in the past 5 years ACA has been profitable.
  • In the past 5 years ACA always reported a positive cash flow from operatings.
ACA Yearly Net Income VS EBIT VS OCF VS FCFACA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

1.2 Ratios

  • ACA's Return On Assets of 4.17% is in line compared to the rest of the industry. ACA outperforms 60.00% of its industry peers.
  • ACA has a Return On Equity (7.88%) which is in line with its industry peers.
  • ACA has a Return On Invested Capital (5.80%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for ACA is significantly below the industry average of 13.89%.
  • The last Return On Invested Capital (5.80%) for ACA is above the 3 year average (4.62%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.17%
ROE 7.88%
ROIC 5.8%
ROA(3y)3.51%
ROA(5y)4%
ROE(3y)6.18%
ROE(5y)6.66%
ROIC(3y)4.62%
ROIC(5y)4.24%
ACA Yearly ROA, ROE, ROICACA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • ACA has a better Profit Margin (7.22%) than 74.55% of its industry peers.
  • In the last couple of years the Profit Margin of ACA has grown nicely.
  • ACA's Operating Margin of 11.37% is fine compared to the rest of the industry. ACA outperforms 78.18% of its industry peers.
  • ACA's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 22.45%, ACA is doing good in the industry, outperforming 70.91% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ACA has grown nicely.
Industry RankSector Rank
OM 11.37%
PM (TTM) 7.22%
GM 22.45%
OM growth 3Y16.52%
OM growth 5Y6.57%
PM growth 3Y-12.89%
PM growth 5Y5.71%
GM growth 3Y5.99%
GM growth 5Y2.61%
ACA Yearly Profit, Operating, Gross MarginsACA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ACA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACA is destroying value.
  • Compared to 1 year ago, ACA has more shares outstanding
  • The number of shares outstanding for ACA has been increased compared to 5 years ago.
  • Compared to 1 year ago, ACA has an improved debt to assets ratio.
ACA Yearly Shares OutstandingACA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
ACA Yearly Total Debt VS Total AssetsACA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 2.64 indicates that ACA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ACA (2.64) is comparable to the rest of the industry.
  • ACA has a debt to FCF ratio of 8.68. This is a slightly negative value and a sign of low solvency as ACA would need 8.68 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 8.68, ACA is in line with its industry, outperforming 52.73% of the companies in the same industry.
  • ACA has a Debt/Equity ratio of 0.57. This is a neutral value indicating ACA is somewhat dependend on debt financing.
  • ACA's Debt to Equity ratio of 0.57 is in line compared to the rest of the industry. ACA outperforms 56.36% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 8.68
Altman-Z 2.64
ROIC/WACC0.54
WACC10.69%
ACA Yearly LT Debt VS Equity VS FCFACA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • ACA has a Current Ratio of 2.20. This indicates that ACA is financially healthy and has no problem in meeting its short term obligations.
  • ACA's Current ratio of 2.20 is amongst the best of the industry. ACA outperforms 85.45% of its industry peers.
  • A Quick Ratio of 1.35 indicates that ACA should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.35, ACA is doing good in the industry, outperforming 63.64% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.35
ACA Yearly Current Assets VS Current LiabilitesACA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ACA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 48.50% over the past year.
  • Measured over the past years, ACA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.78% on average per year.
  • The Revenue has grown by 12.20% in the past year. This is quite good.
  • Measured over the past years, ACA shows a quite strong growth in Revenue. The Revenue has been growing by 8.30% on average per year.
EPS 1Y (TTM)48.5%
EPS 3Y26.66%
EPS 5Y12.78%
EPS Q2Q%150%
Revenue 1Y (TTM)12.2%
Revenue growth 3Y8.74%
Revenue growth 5Y8.3%
Sales Q2Q%7.58%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.28% on average over the next years. This is quite good.
  • Based on estimates for the next years, ACA will show a small growth in Revenue. The Revenue will grow by 5.33% on average per year.
EPS Next Y8.02%
EPS Next 2Y12.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.19%
Revenue Next 2Y5.33%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACA Yearly Revenue VS EstimatesACA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
ACA Yearly EPS VS EstimatesACA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

5

4. ACA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 25.60, ACA can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, ACA is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 27.66, ACA is valued at the same level.
  • ACA is valuated rather expensively with a Price/Forward Earnings ratio of 23.70.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ACA indicates a somewhat cheap valuation: ACA is cheaper than 78.18% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of ACA to the average of the S&P500 Index (38.00), we can say ACA is valued slightly cheaper.
Industry RankSector Rank
PE 25.6
Fwd PE 23.7
ACA Price Earnings VS Forward Price EarningsACA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACA indicates a rather cheap valuation: ACA is cheaper than 81.82% of the companies listed in the same industry.
  • ACA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. ACA is cheaper than 61.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.01
EV/EBITDA 12.57
ACA Per share dataACA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ACA has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as ACA's earnings are expected to grow with 12.28% in the coming years.
PEG (NY)3.19
PEG (5Y)2
EPS Next 2Y12.28%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ACA Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.18%, ACA is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.14, ACA pays a better dividend. On top of this ACA pays more dividend than 81.82% of the companies listed in the same industry.
  • With a Dividend Yield of 0.18, ACA pays less dividend than the S&P500 average, which is at 1.81.
Industry RankSector Rank
Dividend Yield 0.18%

5.2 History

  • The dividend of ACA has a limited annual growth rate of 0.14%.
  • ACA has been paying a dividend for over 5 years, so it has already some track record.
  • As ACA did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)0.14%
Div Incr Years0
Div Non Decr Years6
ACA Yearly Dividends per shareACA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • 4.81% of the earnings are spent on dividend by ACA. This is a low number and sustainable payout ratio.
  • The dividend of ACA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP4.81%
EPS Next 2Y12.28%
EPS Next 3YN/A
ACA Yearly Income VS Free CF VS DividendACA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
ACA Dividend Payout.ACA Dividend Payout, showing the Payout Ratio.ACA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ACA Fundamentals: All Metrics, Ratios and Statistics

ARCOSA INC

NYSE:ACA (4/21/2026, 8:24:35 PM)

After market: 114.43 0 (0%)

114.43

-0.01 (-0.01%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-26
Earnings (Next)04-23
Inst Owners94.28%
Inst Owner Change-0.01%
Ins Owners1.79%
Ins Owner Change8.11%
Market Cap5.62B
Revenue(TTM)2.88B
Net Income(TTM)208.10M
Analysts84
Price Target130.39 (13.95%)
Short Float %2.4%
Short Ratio3.58
Dividend
Industry RankSector Rank
Dividend Yield 0.18%
Yearly Dividend0.2
Dividend Growth(5Y)0.14%
DP4.81%
Div Incr Years0
Div Non Decr Years6
Ex-Date04-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.92%
Min EPS beat(2)15.61%
Max EPS beat(2)24.24%
EPS beat(4)4
Avg EPS beat(4)54.93%
Min EPS beat(4)15.61%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)28.84%
EPS beat(12)11
Avg EPS beat(12)33.04%
EPS beat(16)15
Avg EPS beat(16)36.75%
Revenue beat(2)1
Avg Revenue beat(2)-0.02%
Min Revenue beat(2)-1.23%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-0.48%
Min Revenue beat(4)-3.72%
Max Revenue beat(4)1.83%
Revenue beat(8)3
Avg Revenue beat(8)-1.48%
Revenue beat(12)6
Avg Revenue beat(12)0.12%
Revenue beat(16)10
Avg Revenue beat(16)1.69%
PT rev (1m)3.76%
PT rev (3m)3.26%
EPS NQ rev (1m)-0.62%
EPS NQ rev (3m)-19.37%
EPS NY rev (1m)-0.95%
EPS NY rev (3m)-0.95%
Revenue NQ rev (1m)0.86%
Revenue NQ rev (3m)-2.96%
Revenue NY rev (1m)0.3%
Revenue NY rev (3m)-1.72%
Valuation
Industry RankSector Rank
PE 25.6
Fwd PE 23.7
P/S 1.95
P/FCF 32.01
P/OCF 16.47
P/B 2.13
P/tB 5.72
EV/EBITDA 12.57
EPS(TTM)4.47
EY3.91%
EPS(NY)4.83
Fwd EY4.22%
FCF(TTM)3.57
FCFY3.12%
OCF(TTM)6.95
OCFY6.07%
SpS58.73
BVpS53.8
TBVpS19.99
PEG (NY)3.19
PEG (5Y)2
Graham Number73.5565 (-35.72%)
Profitability
Industry RankSector Rank
ROA 4.17%
ROE 7.88%
ROCE 7.32%
ROIC 5.8%
ROICexc 6.09%
ROICexgc 9.96%
OM 11.37%
PM (TTM) 7.22%
GM 22.45%
FCFM 6.09%
ROA(3y)3.51%
ROA(5y)4%
ROE(3y)6.18%
ROE(5y)6.66%
ROIC(3y)4.62%
ROIC(5y)4.24%
ROICexc(3y)4.82%
ROICexc(5y)4.43%
ROICexgc(3y)8.06%
ROICexgc(5y)7.51%
ROCE(3y)5.83%
ROCE(5y)5.36%
ROICexgc growth 3Y7.62%
ROICexgc growth 5Y-0.63%
ROICexc growth 3Y10.26%
ROICexc growth 5Y1.46%
OM growth 3Y16.52%
OM growth 5Y6.57%
PM growth 3Y-12.89%
PM growth 5Y5.71%
GM growth 3Y5.99%
GM growth 5Y2.61%
F-Score9
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 8.68
Debt/EBITDA 2.75
Cap/Depr 74.26%
Cap/Sales 5.74%
Interest Coverage 3.18
Cash Conversion 61.92%
Profit Quality 84.33%
Current Ratio 2.2
Quick Ratio 1.35
Altman-Z 2.64
F-Score9
WACC10.69%
ROIC/WACC0.54
Cap/Depr(3y)99.71%
Cap/Depr(5y)89.53%
Cap/Sales(3y)7.31%
Cap/Sales(5y)6.45%
Profit Quality(3y)151.62%
Profit Quality(5y)117.46%
High Growth Momentum
Growth
EPS 1Y (TTM)48.5%
EPS 3Y26.66%
EPS 5Y12.78%
EPS Q2Q%150%
EPS Next Y8.02%
EPS Next 2Y12.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.2%
Revenue growth 3Y8.74%
Revenue growth 5Y8.3%
Sales Q2Q%7.58%
Revenue Next Year4.19%
Revenue Next 2Y5.33%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y67.98%
EBIT growth 3Y26.7%
EBIT growth 5Y15.41%
EBIT Next Year75.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.8%
FCF growth 3Y69.09%
FCF growth 5Y-0.26%
OCF growth 1Y-32.05%
OCF growth 3Y25.08%
OCF growth 5Y5.59%

ARCOSA INC / ACA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ARCOSA INC?

ChartMill assigns a fundamental rating of 6 / 10 to ACA.


Can you provide the valuation status for ARCOSA INC?

ChartMill assigns a valuation rating of 5 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.


What is the profitability of ACA stock?

ARCOSA INC (ACA) has a profitability rating of 7 / 10.


What is the expected EPS growth for ARCOSA INC (ACA) stock?

The Earnings per Share (EPS) of ARCOSA INC (ACA) is expected to grow by 8.02% in the next year.


Can you provide the dividend sustainability for ACA stock?

The dividend rating of ARCOSA INC (ACA) is 5 / 10 and the dividend payout ratio is 4.81%.